Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
5.21 Down 0.19(3.52%) 3:59PM EDT
|After Hours : 5.21 0.00 (0.00%) 5:04PM EDT
Prev Close:5.40
Open:5.31
Bid:5.20 x 2000
Ask:5.28 x 200
1y Target Est:9.20
Beta:1.07
Next Earnings Date: 5-Aug-14AVNR Earnings announcement
Day's Range:5.21 - 5.44
52wk Range:2.62 - 6.00
Volume:2,993,259
Avg Vol (3m):2,723,680
Market Cap:832.71M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVNR

Comparison

Symbol% ChgMkt Cap
AVNRDown 3.52%832.71M
BMYDown 0.98%83.92B
LLYDown 2.49%65.44B
GSKDown 0.21%116.18B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.31
Quarterly EPS Est (Jun-14) :-0.08
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-0.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback